---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-005711"
form_type: "8-K"
ticker: "RNXT"
cik: "0001574094"
company_name: "RenovoRx, Inc."
filed_at: "2024-02-09T23:59:59+00:00"
generated_at: "2026-06-06T04:49:49.224898+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# RenovoRx CFO James Ahlers resigns; VP Kocak named Principal Accounting Officer with $235K salary

## Summary
- James Ahlers resigned as CFO effective Feb 5, 2024, for personal reasons; no disagreement with the company.
- Ronald B. Kocak, previously VP and Controller, appointed VP, Controller and Principal Accounting Officer effective Feb 9, 2024.
- Kocak receives $235,000 base salary, up to 35% bonus, and option for 15,000 shares at $1.56, vesting over 4 years with double trigger.
- Kocak will serve as principal financial and accounting officer; CFO position remains unfilled.

## SEC filing metadata
- accession: 0001493152-24-005711
- form_type: 8-K
- ticker: RNXT
- cik: 0001574094
- company_name: RenovoRx, Inc.
- filed_at: 2024-02-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1574094/000149315224005711/0001493152-24-005711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1574094/000149315224005711/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-005711
- JSON: https://secwatch.observer/filing/0001493152-24-005711.json
- Plain text: https://secwatch.observer/filing/0001493152-24-005711.txt

## Key facts
- Executive change
  Ronald B. Kocak was appointed as Vice President, Controller and Principal Accounting Officer at RenovoRx, Inc..
  - Action: appointed
  - Role: Vice President, Controller and Principal Accounting Officer
  source text: On February 8, 2024, the Company’s board of directors (the “Board”), at the recommendation of the audit and compensation committees of the Board, appointed Ronald B. Kocak, CPA, CGMA, the Company’s current Vice President and Controller, to the position of Vice President, Controller and Principal Accounting Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1574094/000149315224005711/0001493152-24-005711-index.htm
- Executive change
  James Ahlers resigned as Chief Financial Officer at RenovoRx, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On February 5, 2024, James Ahlers provided written notice to RenovoRx, Inc. (the “Company”) of his resignation as the Company’s Chief Financial Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1574094/000149315224005711/0001493152-24-005711-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.